Neurology and Neurosurgery - Global Neurology Academy

273-288 of 525

Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
NeuroFrontiers
Social Support in Schizophrenia: The Role of Emotional Awareness and Regulation
David Kimhy, PhD
- David Kimhy, PhD
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple Sclerosis
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Marisa McGinley, DO
- Marisa McGinley, DO
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
NeuroFrontiers
Recognizing Multiple Sclerosis Awareness Month: Ways to Make an Impact
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
On the Frontlines of Multiple Sclerosis
Managing MS-Related Fatigue with Therapeutic, Lifestyle, and Behavioral Interventions
Glenn Wylie, DPhil
- Glenn Wylie, DPhil
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
NeuroFrontiers
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
Natalie Bareis, PhD, LMSW
- Natalie Bareis, PhD, LMSW
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
NeuroFrontiers
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Natalie Bareis, PhD, LMSW
- Natalie Bareis, PhD, LMSW
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
NeuroFrontiers
Fatigue in Multiple Sclerosis: Investigating Longitudinal Determinants
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
NeuroFrontiers
Developments in Duchenne Muscular Dystrophy Care: Examining the Options
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
NeuroFrontiers
Caring for Women with MS: Key Considerations for Pregnancy and Menopause
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
On the Frontlines of Schizophrenia
Schizophrenia Care: Managing Symptoms with Muscarinic Receptor Agonists
Steven Paul, MD
- Steven Paul, MD
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
NeuroFrontiers
Developments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
Steven Paul, MD
- Steven Paul, MD
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiers
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Maxwell H. Levy, MD
- Maxwell H. Levy, MD
Navigating Myasthenia Gravis in Adolescents and Young Adults
Navigating Myasthenia Gravis in Adolescents and Young Adults
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
Jonathan Strober, MD
- Jonathan Strober, MD
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
On the Frontlines of Schizophrenia
Quality of Life in Schizophrenia Patients: Challenges and Practical Approaches to Care
Desiree Matthews, PMHNP-BC
- Desiree Matthews, PMHNP-BC
Spotting the Signs: Early Identification and Management of Schizophrenia
Spotting the Signs: Early Identification and Management of Schizophrenia
On the Frontlines of Schizophrenia
Spotting the Signs: Early Identification and Management of Schizophrenia
Desiree Matthews, PMHNP-BC
- Desiree Matthews, PMHNP-BC
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Gil I. Wolfe MD, FAAN
- Gil I. Wolfe MD, FAAN

18/11